이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
비즈니스 · 1996. 10. 24.1 분 읽기
Guidant Corp.; Premarket Approval of SELUTERegister Steroid Eluting Endocardial Lead Models 4185 and 4285
로컬 자동 번역 · 원본 출처 언어
요약
The Food and Drug Administration (FDA) is announcing its approval of the application by Guidant Corp., St. Paul, MN, for premarket approval, under the Federal Food, Drug, and Cosmetic Act (the act), of SELUTE Steroid Eluting Endocardial Lead Models 4185 and 4285. FDA's Center for Devices and Radiological Health (CDRH) notified the applicant, by letter of May 8, 1996, of the approval of the application.
원본 출처 언어: Federal Register — Food and Drug Administration원문 발표 열기 →